BIOMAT Database Logo BIOMAT Database Logo

[Management with antithrombin III concentrate in a pregnant woman with hereditary antithrombin III deficiency]. 1990

M Higuchi, and H Konya, and H Tanaka, and H Masuda, and Y Nishida, and T Koyama, and A Suehiro, and E Kakishita, and K Ishita
Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya.

Pregnant women with hereditary antithrombin III (AT-III) deficiency are frequently associated with thromboembolic disorders. We have treated a pregnant woman with hereditary AT-III deficiency, who had suffered from thromboembolic disorders at her past three gestations, with AT-III concentrate. Dosage of AT-III concentrate to maintain plasma AT-III activity over 80% was 3,500 units per week during second and third trimesters, but more frequent administration was necessary around delivery. In recent reports, pregnant women with hereditary AT-III deficiency had been treated with heparin or warfarin except for during abortion and delivery, in which time AT-III concentrate was widely utilized. But the use of heparin or warfarin during gestation is occasionally harmful, AT-III concentrate should be chosen for management in pregnancy in women with hereditary AT-III deficiency.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011249 Pregnancy Complications, Cardiovascular The co-occurrence of pregnancy and a cardiovascular disease. The disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS. Cardiovascular Pregnancy Complications,Complications, Cardiovascular Pregnancy,Pregnancy, Cardiovascular Complications,Cardiovascular Pregnancy Complication,Complication, Cardiovascular Pregnancy,Pregnancies, Cardiovascular Complications,Pregnancy Complication, Cardiovascular
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000990 Antithrombin III A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily. Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I
D013923 Thromboembolism Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream. Thromboembolisms
D020152 Antithrombin III Deficiency An absence or reduced level of Antithrombin III leading to an increased risk for thrombosis. Antithrombin 3 Deficiency,Congenital Antithrombin III Deficiency,Deficiency, Antithrombin III,Hereditary Antithrombin Deficiency,Antithrombin 3 Deficiencies,Antithrombin III Deficiencies,Deficiencies, Antithrombin 3,Deficiencies, Antithrombin III,Deficiency, Antithrombin 3

Related Publications

M Higuchi, and H Konya, and H Tanaka, and H Masuda, and Y Nishida, and T Koyama, and A Suehiro, and E Kakishita, and K Ishita
[A case of pregnant woman with hereditary antithrombin-Ⅲ deficiency].
March 2022, Zhonghua fu chan ke za zhi,
M Higuchi, and H Konya, and H Tanaka, and H Masuda, and Y Nishida, and T Koyama, and A Suehiro, and E Kakishita, and K Ishita
The pregnant antithrombin III deficient patient: management without antithrombin III concentrate.
January 1992, Thrombosis research,
M Higuchi, and H Konya, and H Tanaka, and H Masuda, and Y Nishida, and T Koyama, and A Suehiro, and E Kakishita, and K Ishita
Successful administration of recombinant human antithrombin in a pregnant Japanese woman with hereditary antithrombin deficiency.
November 2019, Taiwanese journal of obstetrics & gynecology,
M Higuchi, and H Konya, and H Tanaka, and H Masuda, and Y Nishida, and T Koyama, and A Suehiro, and E Kakishita, and K Ishita
Elimination of antithrombin III concentrate in healthy pregnant and preeclamptic women with an acquired antithrombin III deficiency.
May 1990, Thrombosis research,
M Higuchi, and H Konya, and H Tanaka, and H Masuda, and Y Nishida, and T Koyama, and A Suehiro, and E Kakishita, and K Ishita
Thromboprophylaxis with antithrombin gamma and unfractionated heparin for a pregnant woman complicated by hereditary antithrombin deficiency.
February 2020, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
M Higuchi, and H Konya, and H Tanaka, and H Masuda, and Y Nishida, and T Koyama, and A Suehiro, and E Kakishita, and K Ishita
Effective prophylaxis of thrombosis by antithrombin III concentrate in a pregnant woman with congenital antithrombin III deficiency: relations between plasma antithrombin III activity and the plasma levels of hemostatic molecular markers.
January 1991, Haemostasis,
M Higuchi, and H Konya, and H Tanaka, and H Masuda, and Y Nishida, and T Koyama, and A Suehiro, and E Kakishita, and K Ishita
Antithrombin III concentrate. Thromboprophylaxis during pregnancy in a patient with congenital antithrombin III deficiency.
January 1986, Acta obstetricia et gynecologica Scandinavica,
M Higuchi, and H Konya, and H Tanaka, and H Masuda, and Y Nishida, and T Koyama, and A Suehiro, and E Kakishita, and K Ishita
Antithrombin III concentrate: its catabolism in health and in antithrombin III deficiency.
September 1981, Scandinavian journal of clinical and laboratory investigation,
M Higuchi, and H Konya, and H Tanaka, and H Masuda, and Y Nishida, and T Koyama, and A Suehiro, and E Kakishita, and K Ishita
Hereditary antithrombin III deficiency. Effect of antithrombin III deficiency on platelet function.
August 1976, The American journal of medicine,
M Higuchi, and H Konya, and H Tanaka, and H Masuda, and Y Nishida, and T Koyama, and A Suehiro, and E Kakishita, and K Ishita
Successful outcome in a pregnant woman with homozygous antithrombin deficiency.
December 2007, Thrombosis and haemostasis,
Copied contents to your clipboard!